RAC 2.37% $1.65 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-78

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,060 Posts.
    lightbulb Created with Sketch. 359
    Thanks Phantom.

    As has been addressed, the comparisons aren't quite exact.

    reading many different articles(not race related), there has been an issue with overcoming resistance in "cold" tumours. Is this being addressed specifically by these oncolytic viruses?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.